ARCHIVES

NCI To Fund 160 P01s FY91, About same As Last Year; Considering New ‘Interactive’ R01

This article is from The Cancer Letter archive.

Vol. 17 No. 25 | June 21, 1991

Download PDF Visit The Full Archive

Related Articles

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

New Office For Protection Of Research Subjects Formed.

June 23, 2000

Scientists Tell Panel: Peer Review Need Improving, Available Funds Should Be Spread Over More Grants

April 30, 1982

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979

Agency Approves Two Pairs Of Drugs and Diagnostic Tests

September 30, 2011